Yi-Chun Chen
Papers
1
Total Citations
10
H-Index
1
About
Dr. Yi-Chun Chen is a leading clinical researcher in gynecologic oncology, with a primary focus on optimizing therapeutic strategies for ovarian, tubal, and peritoneal cancers. Her most impactful contribution is the landmark "ROBOT" study, a comprehensive real-world investigation published in 2020 that analyzed eight years of clinical data to evaluate the long-term efficacy and safety of adding bevacizumab to standard chemotherapy. This work, which has garnered 10 citations, provides crucial insights into the prognostic benefits and adverse effects of this targeted therapy specifically in Asian patient populations—a demographic often underrepresented in major clinical trials. By bridging the gap between controlled trial settings and actual clinical practice, Dr. Chen’s research helps refine treatment protocols for both front-line and relapse scenarios. Her dedication to evidence-based, patient-centered outcomes continues to shape how clinicians approach advanced ovarian cancer management, making her work essential reading for oncologists and researchers seeking to improve survival and quality of life for women facing these challenging diagnoses.
Research Focus
Key Achievements
Top Papers
- 1